Evidence map›Paper›PMID 41298897›Full record

ArticleCell research2025

Activation of the SPARDA defense system by filament assembly using a beta-relay signaling mechanism widespread in prokaryotic Argonautes.

Edvinas Jurgelaitis, Evelina Zagorskaitė, Aurimas Kopūstas, Simonas Asmontas, Elena Manakova, Indrė Dalgėdienė, Ugnė Tylenytė, Arunas Silanskas, Paulius Toliusis, Algirdas Grybauskas and 3 more

Abstract read
In one paragraph

Article in Cell research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Edvinas Jurgelaitis *Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Evelina Zagorskaitė *Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Aurimas Kopūstas *Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Simonas Asmontas *Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Elena ManakovaInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Indrė DalgėdienėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.ORCID 0000-0003-4113-4761
Ugnė TylenytėInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.ORCID 0009-0002-9140-1426
Arunas SilanskasInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Paulius ToliusisInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.ORCID 0009-0006-6096-7346
Algirdas GrybauskasInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Marijonas TutkusInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.ORCID 0000-0002-5795-1347
Česlovas VenclovasInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Mindaugas ZarembaInstitute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania. mindaugas.zaremba@bti.vu.lt.ORCID 0000-0002-8606-6304

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101086142Lietuvos Mokslo Taryba (Research Council of Lithuania) S-MIP-23-131Lietuvos Mokslo Taryba (Research Council of Lithuania) S-MIP-24-40Lietuvos Mokslo Taryba (Research Council of Lithuania) S-MIP-24-58
6 · The paper itself

Abstract

Present in all three domains of life, Argonaute proteins use short oligonucleotides as guides to recognize complementary nucleic acid targets. In eukaryotes, Argonautes are involved in RNA silencing, whereas in prokaryotes, they function in host defense against invading DNA. Here, we show that SPARDA (short prokaryotic Argonaute, DNase associated) systems from Xanthobacter autotrophicus (Xau) and Enhydrobacter aerosaccus (Eae) function in anti-plasmid defense. Upon activation, SPARDA nonspecifically degrades both invader and genomic DNA, causing host death, thereby preventing further spread of the invader in the population. X-ray structures of the apo Xau and EaeSPARDA complexes show that they are dimers, unlike other apo short pAgo systems, which are monomers. We show that dimerization in the apo state is essential for inhibition of XauSPARDA activity. We demonstrate by cryo-EM that activated XauSPARDA forms a filament. Upon activation, the recognition signal of the bound guide/target duplex is relayed to other functional XauSPARDA sites through a structural region that we termed the "beta-relay". Owing to dramatic conformational changes associated with guide/target binding, XauSPARDA undergoes a "dimer-monomer-filament" transition as the apo dimer dissociates into the guide/target-loaded monomers that subsequently assemble into the filament. Within the activated filament, the DREN nuclease domains form tetramers that are poised to cleave dsDNA. We show that other SPARDAs also form filaments during activation. Furthermore, we identify the presence of the beta-relay in pAgo from all clades, providing new insights into the structural mechanisms of pAgo proteins. Taken together, these findings reveal the detailed structural mechanism of SPARDA and highlight the importance of the beta-relay mechanism in signal transduction in Argonautes.

Indexed as

Argonaute ProteinsBacterial ProteinsSignal TransductionCrystallography, X-RayModels, MolecularProtein MultimerizationArgonaute ProteinsBacterial Proteins

Identifiers

PMID41298897
PMCPMC12690152

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.